The usage of direct advertising for treatment of melancholy may boost familiarity with potential treatments of the disorder, said Thomas R. Insel, M.D., director of the National Institute of Mental Wellness. However, we must ensure that treatment is based on evidence-based science instead of evidence-based marketing. Critics of direct-to-consumer advertising fear the advertisements lead to over-prescribing. Proponents believe they can serve a useful educational function. This study addresses this issue of over – or under-prescribing. The researchers randomly assigned actors portraying sufferers with symptoms of major major depression or adjustment disorder to create 298 unannounced visits to 152 family physicians and general internists recruited from solo and group methods and health maintenance agencies in California and New York.Current treatment options are tied to their delayed starting point of action, insufficient efficacy and adverse outcomes. The authors conclude that much needs to be explored when it comes to how genes connect to other environmental variables to impact the risk of major depressive disorder. .

Alaska Group to provide health coverage to employees of not-for-profit The Foraker Group, a business that supports not-for-profit organizations in Alaska, on announced that it’ll offer medical health insurance to employees of private Thursday, not-for-profit organizations in the constant state, the Anchorage Daily News reports. The coverage will be offered through Premera Blue Cross Blue Shield of Alaska and will be funded with $2 million from the Rasmuson Foundation.